{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:56:45Z","timestamp":1789736205843,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"EU","award":["POIG.01.01.02-12-004\/09-00"],"award-info":[{"award-number":["POIG.01.01.02-12-004\/09-00"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.bbr.2014.06.029","type":"journal-article","created":{"date-parts":[[2014,6,20]],"date-time":"2014-06-20T12:11:44Z","timestamp":1403266304000},"page":"343-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Pramipexole but not imipramine or fluoxetine reverses the \u201cdepressive-like\u201d behaviour in a rat model of preclinical stages of Parkinson's disease"],"prefix":"10.1016","volume":"271","author":[{"given":"Klemencja","family":"Berghauzen-Maciejewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Kuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wac\u0142aw","family":"Kolasiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"G\u0142owacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dziubina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna","family":"Ossowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga","family":"Wardas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2014.06.029_bib0005","first-page":"19","article-title":"Biochemical pathophysiology of Parkinson's disease","volume":"45","author":"Hornykiewicz","year":"1986","journal-title":"Adv Neurol"},{"key":"10.1016\/j.bbr.2014.06.029_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00536.x","article-title":"Depression in Parkinson's disease\u2014a review","volume":"113","author":"Lieberman","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.bbr.2014.06.029_bib0015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0891988704267456","article-title":"Depression in Parkinson's disease: conceptual issues and clinical challenges","volume":"17","author":"Leentjens","year":"2004","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.bbr.2014.06.029_bib0020","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1002\/mds.23884","article-title":"The Movement Disorder Society Evidence-Based Medicine review update: treatments for the non-motor symptoms of Parkinson's disease","volume":"26","author":"Seppi","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2014.06.029_bib0025","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/187152712800792893","article-title":"Motor and non-motor features of Parkinson's disease\u2014a review of clinical and experimental studies","volume":"11","author":"Lima","year":"2012","journal-title":"CNS Neurol Dis\u2013Drug Targets"},{"key":"10.1016\/j.bbr.2014.06.029_bib0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuropharm.2011.08.039","article-title":"Anxiety in Parkinson's disease: a critical review of experimental and clinical studies","volume":"62","author":"Prediger","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2014.06.029_bib0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.smrv.2012.10.006","article-title":"Sleep disturbances in Parkinson's disease: the contribution of dopamine in REM sleep regulation","volume":"17","author":"Lima","year":"2013","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.bbr.2014.06.029_bib0040","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S1734-1140(13)71516-0","article-title":"Depression in Parkinson's disease","volume":"65","author":"Ossowska","year":"2013","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bbr.2014.06.029_bib0045","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/mds.23092","article-title":"Depression and the subsequent risk of Parkinson's disease in the NIH-AARP diet and health study","volume":"25","author":"Fang","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2014.06.029_bib0050","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/WNL.58.10.1501","article-title":"Increased risk of Parkinson's disease after depression: a retrospective cohort study","volume":"8","author":"Schuurman","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2014.06.029_bib0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.bbr.2014.06.029_bib0060","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain II. Pattern of loss of dopamine-containing neurons in Parkinson's disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2014.06.029_bib0065","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","article-title":"The neuropathologic basis of different clinical subgroups of Parkinson's disease","volume":"50","author":"Paulus","year":"1991","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.bbr.2014.06.029_bib0070","first-page":"870","article-title":"Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT","volume":"44","author":"Kim","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bbr.2014.06.029_bib0075","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.pneurobio.2011.08.009","article-title":"Imaging biomarkers in Parkinson's disease","volume":"95","author":"Brooks","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.bbr.2014.06.029_bib0080","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/mds.22212","article-title":"Elevated serotonin transporter binding in depressed patients with Parkinson\u2018s disease: a preliminary PET study with [11C]DASB","volume":"23","author":"Boileau","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2014.06.029_bib0085","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2014.06.029_bib0090","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/mds.22158","article-title":"Striatal dopamine transporter imaging correlates with depressive symptoms and Tower of London task performance in Parkinson's disease","volume":"23","author":"Rectorova","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2014.06.029_bib0095","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/jnnp-2012-304811","article-title":"Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus","volume":"85","author":"Vriend","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2014.06.029_bib0100","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00259-012-2232-7","article-title":"Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study","volume":"39","author":"Di Giuda","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.bbr.2014.06.029_bib0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbr.2012.01.016","article-title":"Lithium and valproate prevent olfactory discrimination and short-term memory impairment in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease","volume":"229","author":"Castro","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2014.06.029_bib0110","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2014.06.029_bib0115","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2008.07.015","article-title":"Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury","volume":"32","author":"Vu\u010dkovi\u010d","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bbr.2014.06.029_bib0120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbr.2010.05.009","article-title":"Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse","volume":"213","author":"Gorton","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2014.06.029_bib0125","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/jnr.21642","article-title":"Nonmotor symptoms in Parkinson's disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model","volume":"86","author":"Branchi","year":"2008","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bbr.2014.06.029_bib0130","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","article-title":"Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease","volume":"156","author":"Tadaiesky","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2014.06.029_bib0135","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S1734-1140(11)70702-2","article-title":"Partial lesion of the dopaminergic innervation of the ventral striatum induces \u201cdepressive-like\u201d behavior of rats","volume":"63","author":"Kuter","year":"2011","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bbr.2014.06.029_bib0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbr.2007.07.002","article-title":"Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats","volume":"184","author":"Winter","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2014.06.029_bib0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.euroneuro.2006.04.006","article-title":"Effect of antidepressant drugs on 6-OHDA-treated mice in the FST","volume":"17","author":"Chenu","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2014.06.029_bib0150","series-title":"The rat brain","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.bbr.2014.06.029_bib0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2012.08.015","article-title":"6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats","volume":"1477","author":"Kolasiewicz","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2014.06.029_bib0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1254\/jphs.12096SC","article-title":"Pramipexole upregulates dopamine receptor D2 and D3 expression in rat striatum","volume":"120","author":"Tokunaga","year":"2012","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.bbr.2014.06.029_bib0165","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s007020070001","article-title":"The effect of repeated treatment with pramipexole on the central dopamine D3 system","volume":"107","author":"Maj","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2014.06.029_bib0170","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/BF01277669","article-title":"Antidepressant effects of pramipexole, a novel dopamine receptor agonist","volume":"104","author":"Maj","year":"1997","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2014.06.029_bib0175","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/BF02245568","article-title":"Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole","volume":"115","author":"Willner","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2014.06.029_bib0180","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-4328(02)00203-6","article-title":"In the rat forced swimming test, chronic but not subacute administration of dual 5-HT\/NA antidepressant treatments may produce greater effects than selective drugs","volume":"136","author":"R\u00e9n\u00e9ric","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2014.06.029_bib0185","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.pnpbp.2011.07.004","article-title":"LPS inhibits the effect of fluoxetine on depression-like behavior and hippocampal neurogenesis in rats","volume":"35","author":"Wang","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2014.06.029_bib0190","first-page":"219","article-title":"Repeated co-treatment with imipramine and amantadine induces hippocampal brain-derived neurotrophic factor gene expression in rats","volume":"58","author":"Rog\u00f3\u017c","year":"2007","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.bbr.2014.06.029_bib0195","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0006-8993(03)02584-8","article-title":"Effects of chronic exercise and imipramine on mRNA for BDNF after olfactory bulbectomy in rat","author":"Van Hoomissen","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2014.06.029_bib0200","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tins.2004.06.006","article-title":"Putting a spin on the dorsal-ventral divide of the striatum","volume":"27","author":"Voorn","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.bbr.2014.06.029_bib0205","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1046\/j.1460-9568.2003.02800.x","article-title":"Timecourse of striatal re-innervation following lesions of dopaminergic SNpc neurons of the rat","volume":"18","author":"Stanic","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbr.2014.06.029_bib0210","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.neuroscience.2006.05.039","article-title":"Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease","volume":"141","author":"Ossowska","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2014.06.029_bib0215","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1471-4159.2006.04430.x","article-title":"Dopaminergic neurons intrinsic to the striatum","volume":"101","author":"Huot","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2014.06.029_bib0220","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2014.06.029_bib0225","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2014.06.029_bib0230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0014-2999(96)00454-2","article-title":"Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists","volume":"312","author":"Piercey","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2014.06.029_bib0235","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00213-004-1809-7","article-title":"The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors","volume":"175","author":"Siuciak","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2014.06.029_bib0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2011.12.014","article-title":"Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain level of BDNF in mice","volume":"677","author":"Schulte-Herbr\u00fcggen","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2014.06.029_bib0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(97)00066-6","article-title":"The behavioural effects of pramipexole, a novel dopamine receptor agonist","volume":"324","author":"Maj","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2014.06.029_bib0250","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/npp.2008.114","article-title":"Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain","volume":"34","author":"Chernoloz","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2014.06.029_bib0255","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0014-2999(92)90024-X","article-title":"Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist","volume":"215","author":"Mierau","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2014.06.029_bib0260","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s002130051156","article-title":"Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test","volume":"147","author":"Page","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2014.06.029_bib0265","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0149-7634(86)90022-9","article-title":"The effects of tricyclic and atypical antidepressants on spontaneous locomotor activity in rodents","volume":"10","author":"Tucker","year":"1986","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bbr.2014.06.029_bib0270","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/j.1476-5381.1995.tb16684.x","article-title":"Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area","volume":"116","author":"Prisco","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bbr.2014.06.029_bib0275","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/(SICI)1098-2396(199607)23:3<125::AID-SYN1>3.0.CO;2-A","article-title":"Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat","volume":"23","author":"Clark","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2014.06.029_bib0280","first-page":"12","article-title":"Parkinson's syndrome, depression and imipramine","volume":"95","author":"Mandell","year":"1961","journal-title":"Calif Med"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432814004033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432814004033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T06:52:25Z","timestamp":1538549545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432814004033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":56,"alternative-id":["S0166432814004033"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2014.06.029","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pramipexole but not imipramine or fluoxetine reverses the \u201cdepressive-like\u201d behaviour in a rat model of preclinical stages of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2014.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}